Michael Faulkner
Family · Hickory, NCNPI 1467166983
Payments from drug & device makers
Across 117 payments — averaging $14.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$355
- Novo Nordisk$176
- Pfizer$159
- GSK$153
- AstraZeneca$129
- Lilly USA, LLC$87
- plus $636 from 20 others
What the payments were for
- Food & beverage$1,694100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 45 | $355 |
| Novo Nordisk | 12 | $176 |
| Pfizer | 7 | $159 |
| GSK | 7 | $153 |
| AstraZeneca | 7 | $129 |
| Lilly USA, LLC | 5 | $87 |
| Lundbeck LLC | 2 | $60 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $59 |
| Amgen | 3 | $55 |
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| ANI Pharmaceuticals, Inc. | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Boehringer Ingelheim | 3 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Corcept Therapeutics | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| Abbott | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Insulet Corporation | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Merck | 1 | $16 |
| Viatris Specialty LLC | 1 | $15 |
How this compares
$1,694 in reported general payments places this provider in the 80th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 20 | $21,729 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $362 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $291 |
| Doxycycline Monohydrate | 16 | $255 |
| Pantoprazole Sodium | 13 | $179 |
| Alprazolam | 15 | $142 |
| Levothyroxine Sodium | 12 | $120 |
| Prednisone | 20 | $74 |
| Atorvastatin Calcium | 11 | $66 |
| Amlodipine Besylate | 13 | $55 |
| Tizanidine Hcl | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $176 | $21,72920 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,522 family providers in North Carolina.
Other family in Hickory
- Kelly HolmesHickory$55K
- Tanya DyerHickory$21K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.